Peripheral Vascular Disease in Women: Therapeutic Options in 2019

被引:3
|
作者
Saati, Ammar [1 ]
AlHajri, Noora [2 ]
Yaqoub, Lina [3 ]
Ahmed, Waqar [4 ]
Alasnag, Mirvat [4 ]
机构
[1] Kent Hosp, Providence, RI USA
[2] NIA, Div Cardiovasc Sci, NIH, Baltimore, MD 21224 USA
[3] Louisiana State Univ, Shreveport, LA 71105 USA
[4] King Fahd Armed Forces Hosp, Cardiac Ctr, POB 9862, Jeddah 21159, Saudi Arabia
关键词
Peripheral vascular disease; Women; Endovascular revascularization; Surgery;
D O I
10.1007/s11936-019-0769-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review In recent years, there have been advances in the prevention, management, and control of peripheral vascular disease (PVD). There is a trend towards aggressive risk factor modification, noninvasive screening, and endovascular revascularization with surgical approaches reserved only for select cases. This article reviews the different management strategies ranging from pharmacotherapy, revascularization, and rehabilitation with an emphasis on the response of women to these therapies. Recent findings Overall, the representation of women in the majority of the published data in this arena remains poor. Studies examining medical therapy and endovascular and surgical revascularization were not designed to address sex disparities. Nevertheless, we dissect these therapies and their relevant randomized trials. The paucity of data investigating the response of women to the different management options makes it difficult to make any evidence-based recommendations. This not only applies to the type of intervention, but also the appropriate timing and risks entailed.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Peripheral Vascular Disease in Women: Therapeutic Options in 2019
    Ammar Saati
    Noora AlHajri
    Lina Ya’qoub
    Waqar Ahmed
    Mirvat Alasnag
    Current Treatment Options in Cardiovascular Medicine, 2019, 21
  • [2] Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options
    Huang, Boxuan
    Ling, Rongsong
    Cheng, Yifan
    Wen, Jieqi
    Dai, Yarong
    Huang, Wenjie
    Zhang, Siyan
    Lu, Xifeng
    Luo, Yifeng
    Jiang, Yi-Zhou
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 367 - 375
  • [3] Pharmacotherapy for peripheral arterial disease: Emerging therapeutic options
    Jaff, MR
    ANGIOLOGY, 2002, 53 (06) : 627 - 633
  • [4] Peripheral vascular disease and CAD in women
    Mendes, D
    JOURNAL OF FAMILY PRACTICE, 2005, : 2 - 2
  • [5] Therapeutic evaluation of testosterone in peripheral vascular disease
    Beaser, SB
    Massell, TB
    NEW ENGLAND JOURNAL OF MEDICINE, 1942, 227 : 43 - 44
  • [6] THERAPEUTIC DEFIBRINOGENATION IN PERIPHERAL VASCULAR-DISEASE
    ERNST, E
    INTERNATIONAL ANGIOLOGY, 1985, 4 (03) : 373 - 377
  • [7] Therapeutic angiogenesis for treatment of peripheral vascular disease
    Idris, NM
    Haider, HK
    Goh, MWK
    Sim, EKW
    GROWTH FACTORS, 2004, 22 (04) : 269 - 279
  • [8] An Update on Therapeutic Angiogenesis for Peripheral Vascular Disease
    Pacilli, Annalisa
    Faggioli, Gianluca
    Stella, Andrea
    Pasquinelli, Gianandrea
    ANNALS OF VASCULAR SURGERY, 2010, 24 (02) : 258 - 268
  • [9] Diagnostic approaches and potential therapeutic options for coronavirus disease 2019
    Khan, Z.
    Ghafoor, D.
    Khan, A.
    Ualiyeva, D.
    Khan, S. A.
    Bilal, H.
    Khan, B.
    Khan, A.
    Sajjad, W.
    NEW MICROBES AND NEW INFECTIONS, 2020, 38
  • [10] Carnosine as a potential therapeutic for the management of peripheral vascular disease
    Feehan, Jack
    Hariharan, Rohit
    Buckenham, Timothy
    Handley, Charles
    Bhatnagar, Aruni
    Baba, Shahid Pervez
    de Courten, Barbora
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (10) : 2289 - 2296